This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics

Register by September 19 to save $600

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Molly Blevins, PhD
Principal Scientist at Genentech
Speaker

Profile

Dr. Blevins received her B.S. in Chemistry from Northeastern University and her Ph.D. in Analytical Chemistry from the University of Texas at Austin with a focus on bioanalytical mass spectrometry. She joined the Genentech Research & Development (gRED) Synthetic Molecule Analytical Chemistry (SMAC) Department in 2021. She has expertise in analytical method development and control strategy development for new modalities including oligonucleotides, and is especially interested in the development of analytical techniques including mass spectrometry, chromatography, spectrophotometry and calorimetry techniques for oligonucleotide characterization.